Furthermore, in populations with gastrointestinal pathologies, studies have shown a favorable effect of probiotics in the clinical parameters of UC, CD, and NEC through AhR activation by Trp metabolites (i.e., ILA, 5HIAA, IAld, and DHNA). The gene discussed is TNFRSF9; the disease is necrotizing enterocolitis.